What are the causes of a positive direct Coombs test in patients, particularly those with a history of autoimmune disorders, such as Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA), or those who have received blood transfusions or have a history of hemolytic disease of the newborn?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Direct Coombs Test (DAT) Positivity

A positive Direct Coombs test indicates antibody or complement coating on red blood cells, most commonly caused by autoimmune disorders (particularly SLE, rheumatoid arthritis, and autoimmune hepatitis), lymphoproliferative diseases (especially chronic lymphocytic leukemia), drug exposures, infections (including CMV, Mycoplasma, and COVID-19), and transfusion reactions. 1, 2, 3

Primary Autoimmune Causes

Systemic lupus erythematosus is one of the most frequent causes of positive DAT, with 12.8% of SLE patients showing DAT positivity 4. Among these patients:

  • 54.3% develop overt hemolytic anemia 4
  • DAT positivity is independently associated with anti-RNP and anti-La antibodies 4
  • Antibodies such as anti-Sm and anti-RNP are linked to hematological disorders including hemolytic anemia 5

Autoimmune hepatitis demonstrates significant association with positive DAT 5:

  • Concurrent autoimmune hemolytic anemia occurs in AIH patients 5
  • Type 1 AIH is commonly associated with autoimmune thyroid disease 5
  • Type 2 AIH associates with type 1 diabetes, thyroid disease, and autoimmune skin conditions 5

Rheumatoid arthritis and other connective tissue diseases commonly produce positive DAT without overt hemolysis 1, 5

Lymphoproliferative Disorders

Chronic lymphocytic leukemia and non-Hodgkin lymphoma frequently cause positive DAT even without hemolysis 1, 3:

  • These malignancies should be screened with bone marrow biopsy and flow cytometry when DAT is positive with unexplained cytopenias 3
  • The American Society of Clinical Oncology recommends Coombs testing in CLL and NHL patients with anemia 3

Drug-Induced Causes

Medications represent a critical reversible cause requiring thorough drug exposure history 1, 3:

  • Immunosuppressants: tacrolimus, cyclosporine, and sirolimus can cause drug-induced positive DAT without hemolysis 3
  • Immune checkpoint inhibitors cause immune-related autoimmune hemolytic anemia, with 40% of cases showing DAT negativity despite clinical hemolysis 2, 3
  • Sulfasalazine has been documented to cause Coombs-positive hemolytic anemia 6

Infectious Etiologies

Viral infections are increasingly recognized causes of DAT positivity:

  • Cytomegalovirus can induce severe Coombs-positive hemolysis in immunocompetent young adults, with high CMV DNA titers detected by PCR 7
  • Epstein-Barr virus may present with positive DAT and elevated IgM antibodies to viral capsid antigen 7
  • COVID-19 shows significant association with positive DAT in 20% of hospitalized patients 8, likely due to cytokine storm-induced hyperinflammation, complement activation, and RBC alterations 8

Bacterial infections:

  • Mycoplasma pneumoniae causes severe hemolytic anemia with strongly positive direct Coombs test, high cold agglutinin titers with anti-I specificity, and elevated antimycoplasma antibody titers 9

Inflammatory Bowel Disease

Ulcerative colitis associates with autoimmune hemolytic anemia in 1.7% of patients 6:

  • Positive Coombs without hemolysis occurs in 2% of UC patients 6
  • The complication occurs early in disease course (mean 17 months) and relates to disease activity and extent 6
  • 77.7% of Coombs-positive UC patients have total colitis 6

Transfusion-Related Causes

Blood transfusions can cause DAT positivity through:

  • Alloimmunization to red blood cell antigens, requiring maternal blood type, Rh(D) status, and indirect Coombs testing 5
  • Hemolytic disease evaluation requires Kleihauer-Betke stain for fetal hemoglobin 5

Critical Diagnostic Pitfall

Do not assume positive DAT always indicates active hemolysis 3. Confirm with hemolysis markers:

  • LDH, haptoglobin, indirect bilirubin, and reticulocyte count 1, 2, 3
  • Low reticulocyte count with positive DAT indicates antibody sensitization without active hemolysis 1
  • Normal peripheral smear excludes schistocytes or spherocytes suggesting destruction 1

Essential Workup for Positive DAT

When DAT is positive, systematically evaluate:

Hemolysis confirmation: LDH, haptoglobin, indirect bilirubin, reticulocyte count 1, 2

Autoimmune screening: ANA, RF, HLA-B27, anti-RNP, anti-Sm, anti-La 1, 2, 3

Infectious workup: CMV PCR, EBV serology, Mycoplasma antibodies, COVID-19 testing 1, 2, 7, 9

Medication review: Complete drug history including recent additions, particularly immunosuppressants and checkpoint inhibitors 2, 3

Lymphoproliferative evaluation: CBC with differential, peripheral smear, consider bone marrow biopsy if cytopenias present 2, 3

References

Guideline

Positive Direct Coombs Test Without Hemolysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Autoimmune Hemolytic Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Causes of Strong Positive Coombs Test

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Mycoplasma pneumoniae associated with severe autoimmune hemolytic anemia: case report and literature review.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.